Mixed rhenium(I) tricarbonyl complexes for the development of radiopharmaceuticals for CNS-receptor imaging


Mixed rhenium(I) tricarbonyl complexes for the development of radiopharmaceuticals for CNS-receptor imaging

Garcia, R.; Paulo, A.; Domingos, A.; Santos, I.; Spies, H.; Pietzsch, H.-J.; Bergmann, R.; Alberto, R.

The agostic B-H...Re bond in complex [Re{kappa3-H(µ-H)B(timMe)2}(CO)3] (1) (timMe=2-mercapto-1-methylimidazolyl) is easily cleaved by functionalized isonitriles, bearing a (2-methoxyphenyl)piperazine moiety (part of WAY 100635), leading to the novel complexes [Re{kappa3-H(µ-H)B(timMe)2}(C=NR-WAY)(CO)3] (R= butylene (4), pentylene (5) or hexylene (6)). These mixed Re(I) tricarbonyl complexes (4-6) have been fully characterized by the usual analytical techniques, which included X-ray diffraction analysis in case of 4. Complexes 4-6 can be seen as suitable surrogate molecules of potential 99mTc-radiopharmaceuticals for imaging of 5-HT1A subtype of serotonin receptors.

Keywords: Rhenium; isonitriles; poly(mercaptoimidazolyl)borates; 5-HT1A receptors

  • Poster
    6th International Symposium on Technetium in Chemistry and Nuclear Medicine, Bressanone/I, 04.-07.09.2002
  • Contribution to external collection
    In: Technetium, Rhenium and Other Metals in Chemistry and Nuclear Medicine (Edited by Nicolini M., Mazzi U.) SGEditoriali Padova 2002, 143-145

Permalink: https://www.hzdr.de/publications/Publ-5101